{"title":"Neuropilin-2通过Wnt/β-Catenin通路介导鼻咽癌放射耐药","authors":"Jiawei Chen, Huimin Fu, Xiaopeng Huang, Zetan Chen","doi":"10.2147/CMAR.S536248","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Neuropilin-2 (NRP2) is linked to poor prognosis in several malignant tumors. We elucidated the role of NRP2 in radiation resistance in nasopharyngeal carcinoma (NPC) and the underlying molecular pathways.</p><p><strong>Material and methods: </strong>CNE-2R cells of NPC were used for NRP2 knockdown. Stable NRP2 knockdown was achieved using three siRNAs targeting distinct regions of the NRP2 gene. The effect of NRP2 knockdown was confirmed through qPCR for mRNA and Western blot (WB) for protein levels. Assays for cell viability and colony formation were conducted to assess cellular responses to NRP2 knockdown and ionizing radiation. Bioinformatics analyses, including differential expression and pathway enrichment using GEO datasets and GSEA analysis, were performed to elucidate the molecular mechanisms underlying NRP2 function.</p><p><strong>Results: </strong>After NRP2 knockdown in CNE-2R cells, NRP2 expression was significantly lower compared to non-knockdown cells by qPCR and Western blot analysis. NRP2 downregulation in CNE-2R cells led to decreased proliferation and clonal numbers post-radiation in comparison to the control group (P < 0.001). Analysis of the GEO database exhibited that NRP2 expression was notably elevated in nasopharyngeal carcinoma tissues vs normal tissues (p = 0.012). GSEA analysis showed a notable enhancement of the Wnt/β-catenin signaling pathway in NPC, with NES = 1.647, p adjust = 0.049, and FDR = 0.038. The WB analysis indicated that NRP2 knockdown notably reduced the level of WNT3a, Axin2, Cyclin D1, p-GSK3β, and β-catenin in the Wnt/β-catenin pathway in comparison to the negative control group (p < 0.05), with GSK3β expression remaining unchanged.</p><p><strong>Conclusion: </strong>NRP2 is connected with radioresistance in NPC, potentially via Wnt/β-catenin pathway, and may be a potential therapeutic target.</p>","PeriodicalId":9479,"journal":{"name":"Cancer Management and Research","volume":"17 ","pages":"1989-1997"},"PeriodicalIF":2.6000,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476189/pdf/","citationCount":"0","resultStr":"{\"title\":\"Neuropilin-2 Mediates Radioresistance in Nasopharyngeal Carcinoma via Wnt/β-Catenin Pathway.\",\"authors\":\"Jiawei Chen, Huimin Fu, Xiaopeng Huang, Zetan Chen\",\"doi\":\"10.2147/CMAR.S536248\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Neuropilin-2 (NRP2) is linked to poor prognosis in several malignant tumors. We elucidated the role of NRP2 in radiation resistance in nasopharyngeal carcinoma (NPC) and the underlying molecular pathways.</p><p><strong>Material and methods: </strong>CNE-2R cells of NPC were used for NRP2 knockdown. Stable NRP2 knockdown was achieved using three siRNAs targeting distinct regions of the NRP2 gene. The effect of NRP2 knockdown was confirmed through qPCR for mRNA and Western blot (WB) for protein levels. Assays for cell viability and colony formation were conducted to assess cellular responses to NRP2 knockdown and ionizing radiation. Bioinformatics analyses, including differential expression and pathway enrichment using GEO datasets and GSEA analysis, were performed to elucidate the molecular mechanisms underlying NRP2 function.</p><p><strong>Results: </strong>After NRP2 knockdown in CNE-2R cells, NRP2 expression was significantly lower compared to non-knockdown cells by qPCR and Western blot analysis. NRP2 downregulation in CNE-2R cells led to decreased proliferation and clonal numbers post-radiation in comparison to the control group (P < 0.001). Analysis of the GEO database exhibited that NRP2 expression was notably elevated in nasopharyngeal carcinoma tissues vs normal tissues (p = 0.012). GSEA analysis showed a notable enhancement of the Wnt/β-catenin signaling pathway in NPC, with NES = 1.647, p adjust = 0.049, and FDR = 0.038. The WB analysis indicated that NRP2 knockdown notably reduced the level of WNT3a, Axin2, Cyclin D1, p-GSK3β, and β-catenin in the Wnt/β-catenin pathway in comparison to the negative control group (p < 0.05), with GSK3β expression remaining unchanged.</p><p><strong>Conclusion: </strong>NRP2 is connected with radioresistance in NPC, potentially via Wnt/β-catenin pathway, and may be a potential therapeutic target.</p>\",\"PeriodicalId\":9479,\"journal\":{\"name\":\"Cancer Management and Research\",\"volume\":\"17 \",\"pages\":\"1989-1997\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476189/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Management and Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/CMAR.S536248\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Management and Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/CMAR.S536248","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
Neuropilin-2 Mediates Radioresistance in Nasopharyngeal Carcinoma via Wnt/β-Catenin Pathway.
Purpose: Neuropilin-2 (NRP2) is linked to poor prognosis in several malignant tumors. We elucidated the role of NRP2 in radiation resistance in nasopharyngeal carcinoma (NPC) and the underlying molecular pathways.
Material and methods: CNE-2R cells of NPC were used for NRP2 knockdown. Stable NRP2 knockdown was achieved using three siRNAs targeting distinct regions of the NRP2 gene. The effect of NRP2 knockdown was confirmed through qPCR for mRNA and Western blot (WB) for protein levels. Assays for cell viability and colony formation were conducted to assess cellular responses to NRP2 knockdown and ionizing radiation. Bioinformatics analyses, including differential expression and pathway enrichment using GEO datasets and GSEA analysis, were performed to elucidate the molecular mechanisms underlying NRP2 function.
Results: After NRP2 knockdown in CNE-2R cells, NRP2 expression was significantly lower compared to non-knockdown cells by qPCR and Western blot analysis. NRP2 downregulation in CNE-2R cells led to decreased proliferation and clonal numbers post-radiation in comparison to the control group (P < 0.001). Analysis of the GEO database exhibited that NRP2 expression was notably elevated in nasopharyngeal carcinoma tissues vs normal tissues (p = 0.012). GSEA analysis showed a notable enhancement of the Wnt/β-catenin signaling pathway in NPC, with NES = 1.647, p adjust = 0.049, and FDR = 0.038. The WB analysis indicated that NRP2 knockdown notably reduced the level of WNT3a, Axin2, Cyclin D1, p-GSK3β, and β-catenin in the Wnt/β-catenin pathway in comparison to the negative control group (p < 0.05), with GSK3β expression remaining unchanged.
Conclusion: NRP2 is connected with radioresistance in NPC, potentially via Wnt/β-catenin pathway, and may be a potential therapeutic target.
期刊介绍:
Cancer Management and Research is an international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for cancer patients. Specific topics covered in the journal include:
◦Epidemiology, detection and screening
◦Cellular research and biomarkers
◦Identification of biotargets and agents with novel mechanisms of action
◦Optimal clinical use of existing anticancer agents, including combination therapies
◦Radiation and surgery
◦Palliative care
◦Patient adherence, quality of life, satisfaction
The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, and case series that shed novel insights on a disease or disease subtype.